Evofem Biosciences, Inc. Business Finance Contracts & Agreements
122 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (9)
- Forbearance Agreements (2)
- Investor Rights Agreements (2)
- Loan Agreements (1)
- Note Agreements (14)
- Purchase Agreements (29)
- Registration Rights Agreements (16)
- Security Agreements (1)
- Stock Agreements (13)
- Subordination Agreement (1)
- Underwriting Agreements (6)
- Warrant Agreements (27)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of October 28, 2024 (Filed With SEC on October 28, 2024)
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of October 28, 2024 (Filed With SEC on October 28, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of October 2, 2024 (Filed With SEC on October 3, 2024)
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of October 2, 2024 (Filed With SEC on October 3, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of September 20, 2024 (Filed With SEC on September 25, 2024)
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of September 20, 2024 (Filed With SEC on September 25, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of August 9, 2024 (Filed With SEC on August 14, 2024)
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of August 9, 2024 (Filed With SEC on August 14, 2024)
- Registration Rights Agreement, by and between the Company and Aditxt, Inc., dated as of July 12, 2024 (Filed With SEC on July 23, 2024)
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of July 12, 2024 (Filed With SEC on July 23, 2024)
- Asset Purchase Agreement, by and between the Company and Lupin Inc (Filed With SEC on July 18, 2024)
- Form of Amendment and Preferred Exchange Agreement (Filed With SEC on December 27, 2023)
- Form of Waiver and Rights Exchange Agreement (Filed With SEC on December 27, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on December 7, 2023)
- Form of Registration Rights Agreement (Filed With SEC on October 3, 2023)
- Form of Warrant (Filed With SEC on October 3, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on October 3, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on October 3, 2023)
- Fourth Amendment to Securities Purchase and Security Agreement (Filed With SEC on September 11, 2023)
- Form of Exchange Agreement (Filed With SEC on August 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on August 10, 2023)
- Form of Warrant (Filed With SEC on August 10, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on August 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on July 10, 2023)
- Form of Warrant (Filed With SEC on July 10, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on July 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on April 10, 2023)
- Form of Warrant (Filed With SEC on April 10, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on April 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on April 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on March 24, 2023)
- Form of Warrant (Filed With SEC on March 24, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on March 24, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 24, 2023)
- Form of Registration Rights Agreement (Filed With SEC on March 14, 2023)
- Form of Warrant (Filed With SEC on March 14, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on March 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 14, 2023)
